Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
ConclusionFor women with POR, the clinical outcome of the hMG + DYG group was similar to that of the hMG + MPA group, indicating that both combinations can be useful options for PPOS protocols.
Source: Frontiers in Endocrinology - Category: Endocrinology Source Type: research
More News: Endocrinology | ICSI (Intracytoplasmic Sperm Injection) | Medroxyprogesterone | Miscarriage | Ovaries | Pregnancy | Study | Women